12.10.2011 04:30:00
|
Accelrys Announces New Unified Product Suite for Biology Assay and Study Management Needs
Accelrys, Inc. (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, today announced a strategic collaboration with The Edge Software Consultancy Ltd. to offer new assay, study management and analysis software solutions that improve R&D efficiency and productivity for biopharmaceutical organizations engaged in early-stage screening through ADME, DMPK, pharmacology and in vivo experimentation.
Under the terms of the agreement, Accelrys will market and sell software products developed in collaboration with The Edge under the following names:
- Accelrys BioRails DM Suite for general assay and study data management;
- Accelrys BioRails PTO for project tracking and optimization of experiments in BioRails;
- Accelrys Morphit for capturing, analyzing and modeling biological study data.
Accelrys and The Edge will also work to integrate Morphit and BioRails components with Symyx Notebook by Accelrys to deliver flexible templates for structured data management and scientific analysis.
"The new biology data management and analysis solutions made possible by our partnership with The Edge are the next step in building a comprehensive informatics and experiment tracking solution for the biopharmaceutical industry,” said Accelrys President and Chief Executive Officer Max Carnecchia. "By combining the strengths of Symyx Notebook by Accelrys for capturing, managing and reporting unstructured scientific information with The Edge software for capturing, analyzing and managing structured bioassay data, we now offer our customers a best-in-class solution for biology data management.”
"With The Edge’s focus on workflow optimization and improving the productivity of study scientists, we are pleased and excited to be collaborating with Accelrys to bring everything a biologist needs into a single, unified suite,” said Andrew Lemon, managing director, The Edge. "Our design approach has been to minimize complexity and maximize the ease with which scientific data can be captured, which aligns very clearly with Accelrys’ product development philosophy. This, in combination with Accelrys’ proven track record of strong product, customer and partner support makes them the right company to engage with in a strategic collaboration.”
These new biology data management solutions complement Accelrys’ recently announced Cheminformatics Suite of software applications. To learn more about the new Accelrys BioRails products, register for our upcoming webinar, "Biological Data Management with the New Accelrys BioRails Products,” scheduled for Dec. 8, 2011.
About Accelrys, Inc.
Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on science as a differentiator. Accelrys’ Enterprise Research & Development Architecture, built on the industry-leading Pipeline Pilot™ platform, provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. Through its Enterprise R&D Architecture and market-leading electronic laboratory notebooks (ELNs), Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Headquartered in San Diego, Calif., Accelrys has more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries and employs approximately 150 full-time Ph.D. scientists. For more information about Accelrys, visit www.accelrys.com.
About The Edge Consultancy
The Edge provides professional enterprise and desktop solutions and services in support of the biological research and development. Its integrated product suite focuses of on improving productivity at the bench whilst enabling enterprise sharing and exploitation of results. Solutions can be deployed to the desktop, intranet, and or cloud, facilitating collaboration and improved efficiency in a modern R&D environment.
Headquartered in Guildford, Surrey, UK, The Edge has pharmaceutical customers from Europe and the US. For more information about The Edge visit www.edge-ka.com/.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!